首页> 外文期刊>Archives of medical research >Liver biopsy assessment in chronic hepatitis.
【24h】

Liver biopsy assessment in chronic hepatitis.

机译:慢性肝炎的肝活检评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Liver biopsy has been a major diagnostic tool in the evaluation of individuals with chronic hepatitis for many decades and remains the most direct way of visualizing hepatic necroinflammation and fibrosis. In chronic viral hepatitis B and C, immune attack on hepatocytes bearing viral antigens results in the entry of lymphocytes and other effector cells through the portal tracts from which other lesions may evolve, including interface and lobular hepatitis as well as fibrosis or cirrhosis. Classification systems have been developed in order to provide semiquantitative grading of necroinflammation and staging of fibrosis and include the Scheuer, Batts and Ludwig, Ishak, and METAVIR systems. This review provides an historical perspective on histopathological methods of analyzing chronic hepatitis, describes the essential criteria of each of the major scoring systems and discusses problems related to sampling error, observer variation, and specimen size.
机译:数十年来,肝活检一直是评估慢性肝炎患者的主要诊断工具,并且仍然是可视化肝坏死性炎症和纤维化的最直接方法。在慢性乙型和丙型病毒性肝炎中,对携带病毒抗原的肝细胞的免疫攻击导致淋巴细胞和其他效应细胞通过门静脉道进入,其他病变可能从门静脉道演变而来,包括界面和小叶肝炎以及纤维化或肝硬化。为了提供坏死性炎症的半定量分级和纤维化分期,已经开发了分类系统,包括Scheuer,Batts和Ludwig,Ishak和METAVIR系统。这篇综述提供了关于分析慢性肝炎的组织病理学方法的历史观点,描述了每个主要评分系统的基本标准,并讨论了与采样误差,观察者变异和样本大小有关的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号